CYTK Stock Balance Sheets

Cytokinetics Quarterly Balance Sheets Chart

Quarterly

Annual

Account Receivables

Cash and Cash Eq

Account Payables

Deferred Revenue

Cytokinetics Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-09-30	2010-06-30	2010-03-31	2009-09-30	2009-06-30	2009-03-31	2008-09-30	2008-06-30	2008-03-31	2007-09-30	2007-06-30	2007-03-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-06-30	2004-03-31

assets
current assets:
cash and cash equivalents	74,940,000	73,680,000	94,857,000	46,888,000	190,142,000	119,976,000	113,024,000	99,692,000	68,639,000	101,616,000	65,582,000	106,238,000	93,631,000	115,422,000	112,666,000	90,562,000	37,154,000	44,594,000	82,985,000	200,812,000	61,134,000	49,776,000	36,433,000	39,634,000	34,361,000	39,409,000	42,256,000	27,624,000	46,955,000	115,011,000	125,206,000	116,320,000	100,711,000	49,364,000	66,874,000	30,300,000	27,724,000	42,269,000	65,076,000	25,962,000	24,839,000	22,546,000	20,215,000	12,907,000	12,355,000	13,256,000	20,158,000	19,258,000	17,057,000	13,160,000	14,907,000	15,390,000	63,654,000	17,815,000	18,833,000	18,591,000	23,769,000	15,452,000	30,439,000	18,365,000	20,715,000	23,715,000	85,032,000	48,489,000	70,636,000	86,861,000	105,540,000	108,491,000	111,223,000	104,048,000	48,214,000	49,766,000	73,111,000	13,515,000	11,803,000	10,910,000	14,816,000	13,061,000	17,650,000	8,916,000
short-term investments	783,195,000	864,538,000	981,157,000	964,804,000	866,633,000	498,985,000	501,800,000	439,547,000	497,083,000	562,346,000	716,995,000	761,426,000	492,395,000	493,552,000	358,972,000	387,074,000	313,147,000	380,983,000	381,075,000	209,452,000	151,929,000	170,930,000	188,679,000	126,405,000	138,507,000	137,213,000	156,475,000	182,686,000	184,986,000	136,443,000	143,685,000	191,247,000	211,340,000	157,192,000	89,375,000	48,309,000	62,614,000	61,153,000	46,366,000	72,023,000	80,344,000	85,322,000	63,013,000	65,589,000	65,395,000	69,090,000	57,570,000	62,384,000	58,596,000	48,438,000	59,093,000	60,220,000	26,821,000	25,265,000	30,190,000	38,994,000	43,143,000	44,449,000	46,780,000	61,739,000	67,091,000	79,723,000	29,691,000	15,607,000				44,450,000	44,250,000	65,499,000	40,478,000	45,155,000	28,150,000	62,697,000	68,761,000	78,191,000	86,809,000	92,637,000	102,269,000	18,941,000
accounts receivable	8,410,000	2,012,000	16,650,000	244,000		834,000	1,283,000	2,499,000	985,000	1,006,000	147,000	2,294,000	1,973,000	6,056,000	51,819,000	644,000	2,701,000	4,514,000	4,420,000	4,965,000	2,254,000	2,704,000	5,163,000	6,576,000	8,993,000	4,165,000	2,231,000	9,156,000	236,000	37,000	1,112,000	10,000,000																																															13,000
prepaid expenses and other current assets	19,997,000	15,823,000	15,276,000	6,665,000	11,035,000	18,909,000	11,944,000	19,678,000	19,868,000	15,661,000	12,462,000	14,317,000	14,251,000	8,496,000	12,215,000	16,661,000	11,227,000	3,026,000	5,741,000	3,183,000	3,637,000	2,528,000	3,477,000
total current assets	886,542,000	956,053,000	1,107,940,000	1,018,601,000	1,067,810,000	638,704,000	628,051,000	561,416,000	586,575,000	680,629,000	795,186,000	884,275,000	602,250,000	623,526,000	535,672,000	494,941,000	364,229,000	433,117,000	474,221,000	418,412,000	218,954,000	225,938,000	233,752,000	176,535,000	184,951,000	186,400,000	207,674,000	227,269,000	244,229,000	272,339,000	274,295,000	321,987,000	316,996,000	211,023,000	158,633,000	148,184,000	96,618,000	106,118,000	113,107,000	100,515,000	107,900,000	110,810,000	131,131,000	81,491,000	80,078,000	86,054,000	79,338,000	83,321,000	93,620,000	63,665,000	76,427,000	78,769,000	92,960,000	45,221,000	51,140,000	59,871,000	69,804,000	62,954,000	79,258,000	90,139,000	107,089,000	128,151,000	137,100,000	65,332,000	72,783,000	89,335,000	107,510,000	155,205,000	158,021,000	171,660,000	91,413,000	97,590,000	103,107,000	78,864,000	83,655,000	92,282,000	104,825,000		122,777,000	31,131,000
long-term investments	178,201,000	150,687,000	145,055,000	269,168,000	305,361,000	15,376,000	40,534,000	15,468,000	26,871,000	40,406,000	46,708,000	28,544,000	10,668,000	77,083,000	152,050,000	191,295,000	73,672,000	34,664,000	36,954,000	40,958,000		16,510,000	42,650,000		2,254,000					4,015,000	16,518,000	583,000	20,087,000	50,622,000	7,672,000	7,737,000	7,684,000	5,140,000	179,000		3,035,000	9,653,000		4,003,000	14,352,000	19,515,000	2,502,000	3,754,000				5,543,000													18,230,000	18,749,000	19,082,000											4,555,000	11,550,000	7,789,000
property and equipment	70,219,000	67,175,000	65,815,000	64,222,000	65,689,000	68,018,000	68,748,000	75,614,000	77,248,000	78,859,000	80,453,000	80,302,000	78,586,000	75,740,000	73,271,000	53,896,000	36,942,000	23,198,000	13,346,000	7,667,000	5,611,000	5,162,000	4,530,000	3,615,000	2,945,000	3,175,000	3,204,000	2,687,000	2,598,000	3,156,000	3,568,000	3,294,000	3,268,000	3,488,000	3,637,000	2,049,000	1,659,000	1,760,000	1,751,000	1,481,000	1,571,000	1,551,000	1,637,000	1,491,000	1,513,000	1,508,000	1,221,000	804,000	809,000	898,000	997,000	906,000	994,000	1,132,000	1,310,000	1,514,000	1,705,000	2,041,000	2,574,000	2,953,000	3,282,000	3,865,000	4,249,000	4,714,000	5,605,000	6,728,000	7,201,000	7,820,000	8,132,000	8,667,000	7,178,000	5,920,000	5,949,000	6,178,000	5,920,000	6,368,000	6,727,000	7,336,000	7,764,000	8,170,000
operating lease right-of-use assets	76,120,000	77,439,000	75,158,000	76,344,000	77,249,000	78,170,000	78,987,000	79,929,000	80,866,000	81,802,000	82,737,000	75,076,000	72,161,000	72,646,000	73,138,000	80,725,000	83,006,000	79,687,000
other assets	14,553,000	12,697,000	7,705,000	7,725,000	7,679,000	7,814,000	7,996,000	8,187,000	8,339,000	8,119,000	9,691,000	7,764,000	8,052,000	7,258,000	7,188,000	6,682,000	6,453,000	6,396,000						7,243,000	8,068,000	9,036,000	300,000	323,000	412,000	416,000	429,000	449,000	279,000	241,000	200,000	200,000	200,000	200,000	200,000	200,000	200,000	200,000	200,000	200,000	200,000	200,000	127,000	127,000	126,000	127,000	127,000	127,000	127,000	127,000	127,000	178,000	209,000	228,000	298,000	291,000	289,000	296,000	310,000	327,000	372,000	368,000	349,000	324,000	318,000	317,000	442,000	526,000	615,000	796,000	818,000	814,000	794,000	776,000	743,000	734,000
total assets	1,225,635,000	1,264,051,000	1,401,673,000	1,436,060,000	1,523,788,000	808,082,000	824,316,000	740,614,000	779,899,000	889,815,000	1,014,775,000	1,075,961,000	771,717,000	856,253,000	841,319,000	827,539,000	564,302,000	577,062,000	533,803,000	474,112,000	232,495,000	256,582,000	289,814,000	187,393,000	198,218,000	198,611,000	211,178,000	230,279,000	247,239,000	279,926,000	294,810,000	326,313,000	340,630,000	265,374,000	170,142,000	158,170,000	106,161,000	113,218,000	115,237,000	102,196,000	112,706,000	122,214,000	132,968,000	87,185,000	96,143,000	107,277,000	83,188,000	88,006,000	94,555,000	64,690,000	77,551,000	85,345,000	94,081,000	46,531,000	52,773,000	61,778,000	72,157,000	65,662,000	82,918,000	94,616,000	111,893,000	134,164,000	144,069,000	92,922,000	100,043,000	119,366,000	138,338,000	168,702,000	172,812,000	186,995,000	104,649,000	109,578,000	114,668,000	91,461,000	95,901,000	105,202,000	117,832,000		149,503,000	56,169,000
liabilities and stockholders’ deficit
current liabilities:
accounts payable	16,228,000	13,942,000	20,369,000	11,581,000	9,470,000	12,967,000	21,507,000	13,796,000	12,561,000	17,357,000	25,611,000	14,429,000	14,078,000	19,836,000	21,087,000	16,222,000	14,928,000	7,766,000	8,050,000	6,738,000	2,920,000	3,527,000	8,160,000	3,412,000	5,194,000	2,547,000	3,764,000	2,024,000	1,336,000	2,424,000	5,253,000	4,079,000	1,783,000	3,042,000	4,236,000	668,000	2,846,000	547,000	2,238,000	1,907,000	1,601,000	1,392,000	1,361,000	1,646,000	985,000	1,689,000	3,709,000	1,789,000	1,801,000	1,086,000	2,002,000	1,518,000	1,046,000	926,000	1,196,000	1,450,000	1,005,000	1,045,000	1,013,000	1,196,000	1,700,000	1,349,000	924,000	1,256,000	1,013,000	1,659,000	2,306,000	2,505,000	2,221,000	1,815,000	2,448,000	1,890,000	1,617,000	2,352,000	1,366,000	773,000	1,252,000	2,059,000	1,926,000	1,032,000
accrued liabilities	52,315,000	43,358,000	55,323,000	49,826,000	39,813,000	40,123,000	42,641,000	32,954,000	31,470,000	35,632,000	44,096,000	40,229,000	36,702,000	29,477,000	34,370,000	31,772,000	22,394,000	14,806,000	19,315,000	14,486,000	13,688,000	9,677,000	12,123,000	13,139,000	11,828,000	12,944,000	15,757,000	15,652,000	16,090,000	15,545,000	17,392,000	18,455,000	13,545,000	17,503,000	18,047,000	17,783,000	9,503,000	7,877,000	8,421,000	6,759,000	6,429,000	3,981,000	5,400,000	6,012,000	6,911,000	7,678,000	8,272,000	9,886,000	6,706,000	4,690,000	4,877,000	2,942,000	2,943,000	3,541,000	3,232,000	3,263,000	3,737,000	4,279,000	4,446,000	4,411,000	4,281,000	6,207,000	8,230,000	6,569,000	8,750,000	8,024,000	8,190,000	7,292,000	5,740,000	5,647,000	6,424,000	5,502,000	4,215,000	4,137,000	4,282,000	3,994,000	3,780,000	3,697,000	2,918,000	3,407,000
short-term operating lease liabilities	19,585,000	19,574,000	18,978,000	18,856,000	18,507,000	18,230,000	17,891,000	17,236,000	15,701,000	14,263,000	12,829,000	16,056,000	14,303,000	14,490,000	14,863,000
current portion of long-term debt	14,400,000	12,960,000	11,520,000	11,520,000	11,520,000	11,520,000	10,080,000									16,875,000	11,250,000	5,625,000								6,212,000	2,607,000	3,778,000	1,703,000			9,829,000	7,315,000	4,825,000	2,500,000
derivative liabilities measured at fair value	17,600,000	11,700,000	11,300,000	12,500,000	13,200,000
deferred revenue	1,344,000	52,370,000	52,370,000																																																						263,000	17,000			217,000							12,234,000	12,234,000	12,234,000			700,000
other current liabilities	9,592,000	5,822,000	9,814,000	5,529,000	10,267,000	6,015,000	10,559,000	13,737,000	5,885,000	7,968,000	2,081,000	5,782,000	1,760,000	3,044,000	1,540,000	2,413,000	1,004,000	2,438,000	1,049,000	2,406,000	1,013,000	2,507,000	1,124,000	389,000	399,000	75,000	66,000	38,000	28,000	235,000	227,000	424,000	474,000
total current liabilities	131,064,000	159,726,000	179,674,000	109,812,000	102,777,000	88,855,000	102,678,000	77,723,000	65,617,000	75,220,000	84,617,000	76,496,000	66,843,000	66,847,000	71,860,000	80,868,000	61,766,000	35,930,000	31,199,000	27,573,000	22,696,000	20,741,000	26,023,000	21,517,000	21,959,000	26,277,000	22,194,000	21,492,000	27,289,000	38,546,000	32,444,000	42,357,000	31,059,000	36,796,000	33,258,000	29,334,000	26,272,000	24,683,000	31,649,000	30,143,000	29,112,000	25,385,000	23,855,000	12,986,000	16,917,000	19,792,000	26,704,000	45,011,000	34,046,000	5,819,000	7,105,000	4,589,000	3,989,000	4,467,000	4,592,000	5,034,000	5,505,000	6,042,000	6,487,000	6,875,000	17,534,000	20,469,000	23,248,000	22,062,000	24,467,000	24,952,000	26,294,000	26,238,000	24,388,000	23,850,000	12,405,000	10,650,000	9,685,000	11,264,000	10,764,000	10,476,000	12,097,000		10,468,000	9,231,000
term loans	159,058,000	92,025,000	93,227,000	93,017,000	92,831,000
convertible notes	553,987,000	553,143,000	552,370,000	551,481,000	550,600,000	549,790,000	548,989,000	548,134,000	547,288,000	546,513,000	545,808,000	544,986,000	134,674,000	134,511,000	95,471,000	93,885,000	92,348,000	90,889,000	89,504,000	88,102,000	86,743,000	85,455,000	84,205,000
liabilities related to revenue participation right purchase agreements	489,503,000	476,296,000	462,192,000	448,509,000	435,112,000	390,219,000	379,975,000	370,049,000	313,163,000	306,814,000	300,501,000	291,260,000	282,266,000	275,235,000
long-term operating lease liabilities	111,028,000	113,353,000	112,582,000	114,752,000	116,718,000	118,554,000	120,427,000	122,216,000	123,829,000	125,341,000	126,895,000	114,405,000	112,732,000	112,023,000	112,229,000
liabilities related to rpi transactions measured at fair value	147,700,000	133,100,000	137,000,000	132,400,000	117,200,000
other non-current liabilities	2,015,000	2,821,000				2,000	186,000	408,000	625,000	837,000	1,044,000	1,247,000	1,444,000	3,211,000	4,457,000
total liabilities	1,594,355,000	1,530,464,000	1,537,045,000	1,449,971,000	1,415,238,000	1,204,242,000	1,210,639,000	1,179,415,000	1,113,014,000	1,118,835,000	1,122,675,000	1,091,938,000	660,303,000	739,992,000	597,456,000	578,519,000	547,813,000	509,216,000	420,420,000	324,507,000	310,575,000	302,293,000	300,751,000	207,262,000	203,114,000	195,239,000	185,244,000	178,210,000	172,069,000	180,327,000	184,968,000	179,275,000	165,629,000	169,991,000	75,781,000	74,920,000	57,415,000	55,312,000	46,647,000	34,896,000	37,845,000	38,062,000	40,904,000	13,555,000	17,446,000	21,099,000	28,746,000	48,255,000	42,566,000	6,260,000	7,466,000	4,742,000	4,100,000	4,524,000	4,595,000	5,034,000	5,505,000	6,076,000	6,796,000	7,364,000	18,258,000	21,807,000	25,005,000	45,726,000	42,739,000	46,778,000	51,714,000	59,204,000	61,475,000	65,046,000	19,059,000	16,786,000	15,618,000	17,900,000	17,678,000	17,344,000	20,287,000		21,478,000	20,330,000
commitments and contingencies
stockholders' deficit
preferred stock
common stock	119,000	119,000		118,000	117,000	105,000		94,000	94,000	94,000		93,000	85,000	85,000		84,000	72,000	71,000		70,000	60,000	59,000		59,000	58,000	55,000		55,000	55,000	54,000																						142,000	133,000												49,000	49,000	49,000	49,000	47,000	47,000
additional paid-in capital	2,628,829,000	2,595,063,000	2,563,876,000	2,532,328,000	2,500,654,000	1,852,155,000	1,725,823,000	1,537,321,000	1,514,169,000	1,489,814,000	1,481,590,000	1,438,103,000	1,422,127,000	1,406,249,000	1,452,268,000	1,426,051,000	1,117,403,000	1,107,135,000	1,105,470,000	1,096,953,000	865,724,000	857,038,000	853,341,000	813,729,000	799,088,000	775,401,000	768,703,000	765,970,000	762,887,000	757,405,000	755,526,000	752,154,000	748,273,000	639,507,000	612,474,000	609,880,000	607,287,000	604,909,000	603,145,000	592,760,000	591,476,000	590,234,000	589,272,000	579,255,000	578,363,000	577,470,000	537,001,000	528,831,000	528,501,000	519,772,000	518,804,000	517,872,000	517,229,000	460,369,000	456,610,000	453,296,000	452,559,000	431,872,000	425,087,000	423,881,000	417,132,000	411,106,000	409,639,000	393,730,000	384,163,000	382,730,000	381,137,000	376,218,000	366,936,000	365,073,000	301,677,000	294,336,000	287,074,000	249,521,000	243,466,000	243,452,000	243,051,000	243,239,000	242,572,000	7,596,000
accumulated other comprehensive income	-158,000	1,545,000	2,398,000	5,387,000											-869,000	-65,000	-22,000	50,000	149,000	958,000	1,337,000	1,613,000	679,000	719,000	761,000	606,000	500,000	447,000	450,000	489,000	343,000	426,000	-86,000	-9,000	137,000	252,000	229,000	156,000	149,000	16,000	12,000		-4,000	24,000	12,000	12,000	7,000	19,000	-1,000	10,000	18,000	13,000	-1,000	-2,000	3,000	8,000	15,000	9,000	7,000	3,000	-7,000	24,000	-3,000	4,000														-188,000	-89,000	67,000
accumulated deficit	-2,997,510,000	-2,863,140,000	-2,701,764,000	-2,551,744,000	-2,391,199,000	-2,247,881,000	-2,112,238,000	-1,975,342,000	-1,845,920,000	-1,717,283,000	-1,585,994,000	-1,448,614,000	-1,306,304,000	-1,286,484,000	-1,207,620,000	-1,177,050,000	-1,100,964,000	-1,039,410,000	-992,306,000	-948,376,000	-945,201,000	-904,421,000	-865,016,000	-834,376,000	-804,803,000	-772,690,000	-743,324,000	-714,403,000	-688,222,000	-658,349,000	-646,081,000	-605,596,000	-573,239,000	-544,158,000	-518,291,000	-526,923,000	-558,810,000	-547,199,000	-534,744,000	-525,515,000	-516,666,000	-506,115,000	-497,243,000	-505,686,000	-499,715,000	-491,340,000	-482,597,000
total stockholders' deficit	-368,720,000	-266,413,000	-135,372,000	-13,911,000
total liabilities and stockholders' deficit	1,225,635,000	1,264,051,000	1,401,673,000	1,436,060,000
preferred stock, 0.001 par value:
authorized: 10,000,000 shares; issued and outstanding: none
authorized: 163,000,000 shares
issued and outstanding: 118,209,139 shares at december 31, 2024 and 101,637,922 shares at december 31, 2023			118,000
liabilities and stockholders’ equity
stockholders’ equity
accumulated other comprehensive loss					-1,022,000	-539,000	-10,000	-874,000	-1,458,000	-1,645,000	-3,590,000	-5,559,000	-4,494,000	-3,589,000																												-6,000																							-1,795,000	-1,276,000	-948,000	-13,000	-60,000	-54,000	-22,000	-56,000		-14,000	-43,000	-95,000	-181,000
total stockholders’ equity					108,550,000								111,414,000	116,261,000	243,863,000	249,020,000	16,489,000	67,846,000	113,383,000	149,605,000			-10,937,000	-19,869,000	-4,896,000	3,372,000	25,934,000	52,069,000	75,170,000	99,599,000	109,842,000	147,038,000	175,001,000	95,383,000	94,361,000	83,250,000	48,746,000	57,906,000	68,590,000	67,300,000	74,861,000	84,152,000	92,064,000	73,630,000	78,697,000	86,178,000	54,442,000	39,751,000	51,989,000	58,430,000	70,085,000	80,603,000	89,981,000	42,007,000	48,178,000	56,744,000	66,652,000	59,586,000	76,122,000	87,252,000	93,635,000	112,357,000	119,064,000	47,196,000	57,304,000	72,588,000	86,624,000	109,498,000	111,337,000	121,949,000	85,560,000	92,792,000	99,050,000	73,561,000	78,223,000	87,858,000	97,545,000		128,025,000
total liabilities and stockholders’ equity					1,523,788,000								771,717,000	856,253,000	841,319,000	827,539,000	564,302,000	577,062,000	533,803,000	474,112,000			289,814,000	187,393,000	198,218,000	198,611,000	211,178,000	230,279,000	247,239,000	279,926,000	294,810,000	326,313,000	340,630,000	265,374,000	170,142,000	158,170,000	106,161,000	113,218,000	115,237,000	102,196,000	112,706,000	122,214,000	132,968,000	87,185,000	96,143,000	107,277,000	83,188,000	88,006,000	94,555,000	64,690,000	77,551,000	85,345,000	94,081,000	46,531,000	52,773,000	61,778,000	72,157,000	65,662,000	82,918,000	94,616,000	111,893,000	134,164,000	144,069,000	92,922,000	100,043,000	119,366,000	138,338,000	168,702,000	172,812,000	186,995,000	104,649,000	109,578,000	114,668,000		95,901,000	105,202,000	117,832,000
term loan						56,822,000	58,384,000	60,885,000	62,492,000	64,110,000	63,810,000	63,544,000	62,344,000	61,165,000	47,367,000	30,203,000	35,538,000	40,874,000	46,209,000	45,920,000	45,631,000	45,340,000	45,052,000
stockholders’ deficit:
total stockholders’ deficit						-396,160,000	-386,323,000	-438,801,000	-333,115,000	-229,020,000											-78,080,000	-45,711,000																																																										-97,333,000
total liabilities and stockholders’ deficit						808,082,000	824,316,000	740,614,000	779,899,000	889,815,000											232,495,000	256,582,000
issued and outstanding: 101,637,922 shares at december 31, 2023 and 94,833,975 shares at december 31, 2022							102,000
preferred stock, 0.001 par value
liabilities and stockholders’ (deficit) equity
long-term deferred revenue														87,000,000	87,000,000	87,000,000	87,000,000	87,000,000	87,000,000
stockholders’ (deficit) equity:
issued and outstanding: 94,833,975 shares at december 31, 2022 and 84,799,542 shares at december 31, 2021											94,000
total stockholders’ (deficit) equity											-107,900,000	-15,977,000
total liabilities and stockholders’ (deficit) equity											1,014,775,000	1,075,961,000
stockholders’ equity:
liabilities related to revenue participation right purchase agreement															179,072,000
issued and outstanding: 84,799,542 shares at december 31, 2021 and 71,015,183 shares at december 31, 2020															84,000
short-term lease liabilities																13,586,000	12,190,000	5,295,000
liability related to the sale of future royalties																174,775,000	171,790,000	168,890,000	166,068,000	160,395,000	154,914,000	148,983,000	143,276,000	137,726,000	132,388,000	127,308,000	122,473,000	117,718,000	113,144,000	108,792,000	104,650,000	100,575,000	96,657,000	92,928,000
long-term lease and other non-current liabilities																111,788,000	99,371,000		440,000	2,517,000
long-term lease liabilities																		85,633,000
operating lease right-of-use assets and other assets																			9,282,000	7,075,000	7,930,000	8,972,000	8,882,000
short-term lease liability																			2,785,000	3,943,000	5,075,000	5,030,000	4,616,000	4,577,000	4,538,000	4,499,000
issued and outstanding: 71,015,183 shares at december 31, 2020 and 59,172,124 shares at december 31, 2019																			70,000
long-term lease liability																					591,000	1,774,000	2,195,000	3,257,000	4,294,000	5,272,000
revenues:
research and development revenues																						3,825,000
total revenues																						3,825,000																																																										5,867,000
operating expenses:
research and development																						21,738,000																																																										9,360,000
general and administrative																						12,449,000																																																										2,475,000
total operating expenses																						34,187,000																																																										11,835,000
operating income																						-30,362,000																																																										-5,968,000
interest expense																						-4,077,000
non-cash interest expense on liability related to the sale of future royalties																						-5,689,000
interest and other income																						723,000																																																										519,000
net income																						-39,405,000																																																										-5,932,000
net income per share																						-660
weighted-average number of shares used in computing net income per share — basic and diluted																						59,270,000
other comprehensive income:
unrealized gain on available-for-sale securities																						934,000
comprehensive loss																						-38,471,000
contract assets																									575,000	2,472,000	4,554,000	5,876,000	10,375,000	18,550,000
issued and outstanding: 59,172,124 shares at december 31, 2019 and 54,717,906 shares at december 31, 2018																							59,000
prepaid and other current assets																								3,920,000	2,515,000	3,141,000	2,158,000	1,927,000	1,677,000	2,298,000	4,292,000	4,420,000	4,945,000	3,557,000	2,360,000	2,575,000	6,254,000	2,696,000	1,653,000	2,483,000	2,713,000	1,972,000	1,257,000	1,804,000	2,009,000	1,592,000	1,605,000	1,679,000	1,967,000	1,739,000	2,423,000	3,159,000	2,482,000	2,058,000	2,103,000	2,170,000	2,865,000	3,019,000	1,777,000	2,349,000	1,613,000	2,010,000	1,840,000	1,189,000	2,001,000	2,337,000	1,735,000	2,007,000	2,356,000	1,754,000	2,498,000	2,438,000	1,645,000	1,925,000	1,768,000	2,572,000	2,419,000	2,603,000
long-term debt																								44,762,000	44,473,000	36,382,000	39,806,000	38,127,000	30,662,000	31,954,000	31,777,000	20,471,000	22,844,000	25,195,000	27,381,000	29,742,000	29,604,000	29,466,000	14,639,000
other long-term liabilities																											771,000	873,000	974,000	1,035,000	1,097,000		2,000
deferred revenue, current																														4,506,000	9,572,000	9,570,000	7,942,000	10,974,000	8,060,000	10,497,000	13,559,000	15,911,000	20,858,000	21,367,000	20,993,000	19,942,000	17,042,000	5,284,000	8,984,000	10,396,000	14,701,000	33,322,000	25,529,000
deferred revenue, non-current																															15,000,000	15,872,000	15,067,000	15,000,000	15,000,000	15,635,000	1,275,000	851,000		4,346,000	8,293,000	12,211,000	16,558,000	52,000		772,000	1,500,000	2,696,000	8,000,000
issued and outstanding: 54,717,906 shares at december 31, 2018 and 53,960,832 shares at december 31, 2017																											55,000
contract liabilities																													8,132,000	15,836,000
authorized: 163,000,000
issued and outstanding: 53,960,832 shares at december 31, 2017 and 40,646,595 shares at december 31, 2016																															54,000
authorized: 10,000,000 shares;
issued and outstanding: series a convertible preferred stock — zero shares at september 30, 2017 and december 31, 2016
authorized: 163,000,000 shares;
issued and outstanding: 53,862,617 shares at september 30, 2017 and 40,646,595 shares at december 31, 2016																																54,000
issued and outstanding: series a convertible preferred stock — zero shares at june 30, 2017 and december 31, 2016
issued and outstanding: 53,457,091 shares at june 30, 2017 and 40,646,595 shares at december 31, 2016																																	53,000
related party accounts receivable																																		910,000	24,000	67,000,000	26,000		12,000	47,000	4,000	970,000	46,646,000				5,000			328,000	4,000		3,000	83,000	14,000	116,000	27,000	34,000	262,000	211,000	11,000	4,544,000	522,000	7,000	69,000	60,000	58,000	130,000	65,000	133,000	63,000	71,000	50,000	576,000	984,000	211,000	131,000	53,000		204,000
short-term portion of deferred rent and interest payable																																		452,000	415,000	386,000	364,000	348,000
long-term portion of deferred rent																																		72,000	142,000	209,000	264,000	312,000	359,000	407,000	440,000	466,000	491,000	517,000	529,000	535,000	542,000	548,000	520,000	441,000	361,000	153,000	111,000	57,000	3,000
issued and outstanding: series a convertible preferred stock — zero shares at march 31, 2017 and december 31, 2016
issued and outstanding: 43,417,342 shares at march 31, 2017 and 40,646,595 shares at december 31, 2016																																		43,000
issued and outstanding: series a convertible preferred stock — zero shares at december 31, 2016 and december 31, 2015
authorized: 163,000,000 shares at december 31, 2016 and 81,500,000 shares at december 31, 2015;
issued and outstanding: 40,646,595 shares at december 31, 2016 and 39,581,692 shares at december 31, 2015																																			41,000
issued and outstanding: series a convertible preferred stock — zero shares at september 30, 2016 and december 31, 2015
authorized: 81,500,000 shares;
issued and outstanding: 40,516,892 shares at september 30, 2016 and 39,581,692 shares at december 31, 2015																																				41,000
issued and outstanding: series a convertible preferred stock — zero shares at june 30, 2016 and december 31, 2015
issued and outstanding: 39,697,508 shares at june 30, 2016 and 39,581,692 shares at december 31, 2015																																					40,000
issued and outstanding: series a convertible preferred stock — zero shares at march 31, 2016 and december 31, 2015
issued and outstanding: 39,607,437 shares at march 31, 2016 and 39,581,692 shares at december 31, 2015																																						40,000
short-term portion of deferred rent																																							132,000	110,000	89,000	70,000	52,000	44,000	37,000	29,000	22,000	14,000	10,000	43,000	76,000
issued and outstanding: series a convertible preferred stock — zero shares at december 31, 2015 and december 31, 2014
issued and outstanding: 39,581,692 shares at december 31, 2015 and 38,659,738 shares at december 31, 2014																																							40,000
issued and outstanding: series a convertible preferred stock — zero shares at september 30, 2015 and december 31, 2014
issued and outstanding: 38,756,313 shares at september 30, 2015 and 38,659,738 shares at december 31, 2014																																								39,000
issued and outstanding: series a convertible preferred stock — zero shares at june 30, 2015 and december 31, 2014
issued and outstanding: 38,728,921 shares at june 30, 2015 and 38,659,738 shares at december 31, 2014																																									39,000
issued and outstanding: series a convertible preferred stock — zero shares at march 31, 2015 and december 31, 2014
issued and outstanding: 38,716,905 shares at march 31, 2015 and 38,659,738 shares at december 31, 2014																																										39,000
issued and outstanding: series a convertible preferred stock — zero shares at december 31, 2014 and december 31, 2013
issued and outstanding: 38,659,738 shares at december 31, 2014 and 30,681,624 shares at december 31, 2013																																											39,000
accounts receivable and related party receivable																																												1,191,000	319,000	2,116,000
authorized: 10,000,000 shares; issued and outstanding, none
issued and outstanding: 36,608,781 shares at september 30, 2014 and 30,681,624 shares at december 31, 2013																																												37,000
issued and outstanding: 36,608,781 shares at june 30, 2014 and 30,681,624 shares at december 31, 2013																																													37,000
issued and outstanding: 36,090,071 shares at march 31, 2014 and 30,681,624 shares at december 31, 2013																																														36,000
related party payables and accrued liabilities																																																			150,000				12,000	11,000	11,000	11,000			10,000	10,000	10,000	15,000	10,000	6,000	22,000	36,000	76,000	115,000	216,000	268,000	390,000	649,000
authorized: 10,000,000 shares ; issued and outstanding:
series a convertible preferred stock — zero shares at december 31, 2013 and december 31, 2012
series b convertible preferred stock — zero shares at december 31, 2013 and 23,026 shares at december 31, 2012
issued and outstanding: 30,681,624 shares at december 31, 2013 and 23,742,911 shares at december 31, 2012																																															31,000
issued and outstanding: series b convertible preferred stock — 0 shares at september 30, 2013 and 23,026 shares at december 31, 2012
issued and outstanding: 29,503,123 shares at september 30, 2013 and 23,742,911 shares at december 31, 2012																																																29,000
deficit accumulated during the development stage																																																-489,128,000	-476,540,000	-461,499,000	-448,880,000	-437,424,000	-427,380,000	-418,438,000	-408,510,000	-396,632,000	-385,994,000	-372,362,000	-349,037,000	-336,696,000	-323,552,000	-298,834,000	-290,633,000	-346,592,000	-325,051,000	-308,791,000	-293,427,000	-266,280,000	-254,959,000	-242,331,000	-214,693,000	-199,773,000	-185,987,000	-173,524,000	-162,443,000	-152,342,000	-141,802,000	-131,272,000	-109,237,000	-100,006,000
license fee receivable																																																	16,000,000
issued and outstanding: series b convertible preferred stock — 4,000 shares at june 30, 2013 and 23,026 shares at december 31, 2012
issued and outstanding: 28,685,215 shares at june 30, 2013 and 23,742,911 shares at december 31, 2012																																																	29,000
authorized: 10,000,000 shares; issued and outstanding:
series b convertible preferred stock — 19,026 shares at march 31, 2013 and 23,026 shares at december 31, 2012
authorized: 245,000,000 shares;
issued and outstanding: 146,463,469 shares at march 31, 2013 and 142,457,469 shares at december 31, 2012																																																		147,000
restricted cash																																																						51,000	196,000	215,000	439,000	439,000	788,000	1,233,000	1,233,000	1,674,000	2,232,000	2,232,000	2,750,000	4,147,000	4,147,000	5,167,000	6,125,000	6,125,000	5,204,000	5,100,000	4,546,000	5,172,000	4,936,000	5,136,000	5,136,000	5,980,000	5,523,000	7,199,000
short-term portion of equipment financing lines																																																							152,000	310,000	489,000	690,000	1,028,000	1,268,000	1,453,000	1,725,000	1,797,000	1,925,000	2,460,000	3,029,000	3,542,000	4,171,000	4,117,000	4,039,000	3,317,000	2,990,000	2,763,000	2,726,000	2,608,000	2,448,000	2,421,000	2,387,000	2,108,000	1,992,000
series a convertible preferred stock — zero shares at december 31, 2012 and 8,070 shares at december 31, 2011
series b convertible preferred stock — 23,026 shares at december 31, 2012 and zero shares at december 31, 2011
issued and outstanding: 142,457,469 shares at december 31, 2012 and 74,915,739 shares at december 31, 2011																																																			143,000
short-term portion of deferred revenue																																																				129,000										708,000		12,297,000	12,234,000	12,234,000	12,234,000							1,400,000	2,100,000	2,800,000	4,299,000	2,800,000	2,800,000	2,800,000
commitments and contingencies stockholders’ equity:
series a convertible preferred stock — zero shares at september 30, 2012 and 8,070 shares at december 31, 2011;
series b convertible preferred stock — 23,026 shares at september 30, 2012 and zero shares at december 31, 2011
authorized: 245,000,000 shares; issued and outstanding: 142,413,069 shares at september 30, 2012 and 74,915,739 shares at december 31, 2011
series a convertible preferred stock — 8,070 shares at june 30, 2012 and december 31, 2011;
series b convertible preferred stock — 23,026 shares at june 30, 2012 and zero shares at december 31, 2011
authorized: 245,000,000 shares; issued and outstanding: 133,478,796 shares at june 30, 2012 and 74,915,739 shares at december 31, 2011
authorized: 10,000,000 shares issued and outstanding: series a convertible preferred stock — 8,070 shares at march 31, 2012 and december 31, 2011
authorized: 245,000,000 shares issued and outstanding: 77,512,080 shares at march 31, 2012 and 74,915,739 shares at december 31, 2011																																																						78,000
long-term portion of equipment financing lines																																																										34,000	309,000	489,000	724,000	1,338,000	1,757,000	2,187,000	3,081,000	3,576,000	4,112,000	5,541,000	6,604,000	7,654,000	6,654,000	6,136,000	5,933,000	6,636,000	6,914,000	6,868,000	7,490,000	8,106,000	8,210,000	7,599,000
authorized: 10,000,000 shares in 2011 and 2010
issued and outstanding: series a convertible preferred stock — 8,070 shares in 2011 and zero shares in 2010
authorized: 245,000,000 shares in 2011 and 170,000,000 in 2010
issued and outstanding: 74,915,739 shares in 2011 and 66,907,600 shares in 2010																																																							75,000
authorized: 10,000,000 shares at september 30, 2011 and december 31, 2010
issued and outstanding: series a convertible preferred stock — 8,070 shares at september 30, 2011 and zero shares at december 31, 2010
authorized: 245,000,000 shares at september 30, 2011 and 170,000,000 shares at december 31, 2010
issued and outstanding: 72,279,751 shares at september 30, 2011 and 66,907,600 shares at december 31, 2010																																																								72,000
authorized: 10,000,000 shares at june 30, 2011 and december 31, 2010
issued and outstanding: series a convertible preferred stock — 8,070 shares at june 30, 2011 and zero shares at december 31, 2010
authorized: 170,000,000 shares at june 30, 2011 and december 31, 2010
issued and outstanding: 72,279,751 shares at june 30, 2011 and 66,907,600 shares at december 31, 2010																																																									72,000
convertible preferred stock:
authorized: 10,000,000 shares at march 31, 2011 and december 31, 2010 issued and outstanding: zero shares at march 31, 2011 and december 31, 2010
authorized: 170,000,000 shares at march 31, 2011 and december 31, 2010 issued and outstanding: 66,916,100 shares at march 31, 2011 and 66,907,600 shares at december 31, 2010																																																										67,000
investments in auction rate securities																																																												6,698,000	15,311,000	15,782,000	17,254,000	17,306,000
investment put option related to auction rate securities rights																																																												777,000	2,339,000	2,368,000	2,721,000
related party notes receivable																																																													9,000													451,000			350,000	387,000	1,146,000	1,146,000
loan with ubs																																																													9,873,000	10,470,000	12,287,000	12,355,000
authorized: 170,000,000 shares; issued and outstanding: 64,572,009 shares at september 30, 2010 and 61,275,036 shares at december 31, 2009																																																											65,000
authorized: 170,000,000 shares; issued and outstanding: 64,513,092 shares at june 30, 2010 and 61,275,036 shares at december 31, 2009																																																												64,000
authorized: 170,000,000 shares; issued and outstanding: 62,479,802 shares at march 31, 2010 and 61,275,036 shares at december 31, 2009																																																													62,000
related party notes receivable — short-term portion																																																														9,000	40,000	40,000	77,000	77,000	177,000	127,000	127,000	226,000	160,000	160,000	151,000	151,000	339,000	398,000	650,000	713,000
assets held-for-sale																																																														178,000	178,000	283,000	294,000
related party notes receivable — long-term portion																																																																9,000	9,000	39,000	49,000	186,000	216,000	226,000	412,000	442,000	451,000
long-term portion of deferred revenue																																																																9,122,000	15,191,000	18,250,000	21,308,000	27,425,000	30,483,000	33,542,000							700,000	1,400,000	2,800,000	3,500,000
authorized: 170,000,000 shares; issued and outstanding: 60,908,591 shares at september 30, 2009 and 49,939,069 shares at december 31, 2008																																																														61,000
authorized: 170,000,000 shares; issued and outstanding: 60,790,925 shares at june 30, 2009 and 49,939,069 shares at december 31, 2008																																																															61,000
investment in put option																																																																2,719,000
authorized: 170,000,000 shares; issued and outstanding:
53,560,417 shares at march 31, 2009 and 49,939,069 shares at december 31, 2008																																																																54,000
deferred stock-based compensation																																																																	-62,000	-124,000	-187,000	-476,000	-627,000	-786,000	-1,410,000	-1,752,000	-2,073,000	-2,452,000	-2,786,000	-3,186,000	-3,552,000	-4,251,000	-5,249,000	-4,993,000
convertible preferred stock, 0.001 par value:
authorized: 120,000,000 shares; issued and outstanding: 37,793,573 shares in 2006 and 29,710,895 shares in 2005																																																																							38,000
authorized: 120,000,000 shares; issued and outstanding: 36,613,565 shares in 2006 and 29,710,895 shares in 2005																																																																								37,000
authorized: 120,000,000 shares; issued and outstanding: 35,595,682 shares in 2006 and 29,710,895 shares in 2005																																																																									36,000
liabilities, convertible preferred stock and stockholders’ equity
commitments
authorized: 10,000,000 shares
issued and outstanding: none in 2005 and 2004
authorized: 120,000,000 shares
issued and outstanding: 29,710,895 shares in 2005 and 28,453,173 shares in 2004																																																																										30,000
total liabilities, convertible preferred stock and stockholders’ equity																																																																										91,461,000					149,503,000
related party notes receivable— long-term portion																																																																											572,000	602,000
related party accrued liabilities																																																																											408,000	461,000	345,000	96,000	716,000
authorized: 120,000,000 shares; issued and outstanding: 28,660,743 shares in 2005 and 28,453,173 shares in 2004																																																																											29,000
authorized: 120,000,000 shares; issued and outstanding: 28,621,634 shares in 2005 and 28,453,173 shares in 2004																																																																												29,000
authorized: 120,000,000 shares; issued and outstanding: 28,509,600 shares in 2005 and 28,453,173 shares in 2004																																																																													29,000
related party receivable																																																																															185,000
prepaids and other current assets																																																																															2,660,000	3,070,000
convertible preferred stock, 0.001 par value
authorized: 37,300,000 shares
issued and outstanding: none in 2004 and 34,128,308 shares in 2003
authorized: 61,500,000 shares
issued and outstanding: 28,332,339 shares in 2004 and 2,307,258 shares in 2003																																																																															28,000
liabilities, convertible preferred stock and stockholders’ deficit
issued and outstanding: 34,128,308 shares in 2004 and in 2003
stockholders’ deficit
issued and outstanding: 2,623,199 shares in 2004 and 2,307,258 shares in 2003																																																																																3,000
total liabilities, convertible preferred stock and stockholders’ deficit																																																																																56,169,000
research and development revenues from related party																																																																																5,067,000
research and development and grant revenues																																																																																100,000
license revenues from related party																																																																																700,000
basic and diluted																																																																																-2,560
weighted- average number of shares used in per share calculations:
includes the following stock-based compensation charges:

We provide you with 20 years of balance sheets for Cytokinetics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Cytokinetics. Explore the full financial landscape of Cytokinetics stock with our expertly curated balance sheets.

The information provided in this report about Cytokinetics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.